There were 2,105 press releases posted in the last 24 hours and 440,838 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Syndax and Merck to Collaborate on Immuno-Oncology Study Evaluating Entinostat in Combination with KEYTRUDA® (pembrolizumab) in Lung Cancer and Melanoma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image